#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Rhabdoid tumour Anti-glomerular basement membrane disease Turner's syndrome Hormone-dependent prostate cancer Hodgkin's disease refractory Inborn error of metabolism Growth hormone deficiency Pleomorphic leiomyosarcoma Ductal adenocarcinoma of pancreas Juvenile idiopathic arthritis Dilated cardiomyopathy B-cell lymphoma Lymphangioma Toxic epidermal necrolysis Neonatal alloimmune thrombocytopenia More trials…

    Learn about Rare Diseases

    Adrenogenital syndrome – Diagnostics Acquired haemophilia Hereditary neuropathic amyloidosis – Trials in Disease Proteus syndrome – Trials in Disease Haemophilia A without inhibitors – Life with Disease Waldenstrom’s macroglobulinaemia Aicardi-Goutieres syndrome – Basic Information Mitochondrial myopathy – Treatment Metachromatic leukodystrophy – Life with Disease Kearns-Sayre syndrome – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Cusatuzumab Telitacicept Ampicillin Amlitelimab Mdna11 Atazanavir HEMOPEXIN, HUMAN Iopamidol Indocyanine Green Naloxegol Oxalate Img-007 Nvl-655 Bi-1808 Noradrenaline Tartrate BMS-986365 XENON (133XE) Citalopram Hydrochloride Azd9550 ADCE-D01 IHMA-2121771-2 More therapies…

    Learn about Your Condition

    Arrhythmia Immune-mediated enterocolitis Hodgkin's disease Ebola disease Cardiogenic shock Systemic scleroderma Oesophagectomy Neuropathic arthropathy Adrenal insufficiency Infective uveitis Bladder cancer stage III Benign renal neoplasm Iron deficiency anaemia Primary hypogonadism Mitochondrial DNA depletion More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Digestive System Diseases

  • Study of Saccharomyces boulardii CNCM I-745 to treat symptoms in adults with non-constipated Irritable Bowel Syndrome

    Recruiting

    3 1 1
    Investigated Drugs:
    • Loperamide Hydrochloride
    • Saccharomyces Boulardii Cncm I-745 Lyophilized
    Portugal Spain

  • Study of ivosidenib maintenance treatment in patients with IDH1-mutated cholangiocarcinoma after standard chemotherapy

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • Cholangiocarcinoma
    Investigated Drugs:
    • Ivosidenib
    Germany

  • Study of MP0317 with durvalumab, gemcitabine and cisplatin combination therapy as first-line treatment for patients with advanced biliary tract cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Biliary neoplasm
    Investigated Drugs:
    • Cisplatin
    • Durvalumab
    • Gemcitabine
    France

  • Study of SAR444336 in Adults with Microscopic Colitis Who Achieved Clinical Remission with Budesonide Treatment

    Recruiting

    2 1
    Investigated Drugs:
    • SAR444336
    Belgium Denmark France Germany Hungary Italy +2

  • Study of Zolbetuximab combined with Paclitaxel and Ramucirumab for patients with previously treated CLDN18.

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Oesophageal adenocarcinoma
    Investigated Drugs:
    • Zolbetuximab
    Belgium

  • Evaluating intravenous lidocaine with intrathecal morphine for pain control in patients undergoing major abdominal surgery through laparotomy

    Recruiting

    3 1 1
    Investigated Drugs:
    • Lidocaine Hydrochloride Monohydrate
    • Sodium Chloride
    France
Previous Page
1 … 6 7 8 9 10 … 93
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!